|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
8
|
|
pubmed:dateCreated |
1999-11-16
|
|
pubmed:abstractText |
This multicenter phase II study was designed to assess the efficacy of the alternating schedule of tomudex with methotrexate (MTX)/5-fluorouracil (5-FU)/leucovorin (LV) in first-line chemotherapy for metastatic colorectal cancer.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
0923-7534
|
|
pubmed:author |
pubmed-author:AgostinelliRR,
pubmed-author:BaldelliA MAM,
pubmed-author:Bari?LL,
pubmed-author:CascinuSS,
pubmed-author:CatalanoGG,
pubmed-author:CatalanoVV,
pubmed-author:FrontiniLL,
pubmed-author:GaspariniGG,
pubmed-author:GiuliodoriLL,
pubmed-author:LabiancaRR,
pubmed-author:MartignoniGG,
pubmed-author:MattioliRR,
pubmed-author:SilvaR RRR
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
10
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
985-7
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:10509163-Adenocarcinoma,
pubmed-meshheading:10509163-Adult,
pubmed-meshheading:10509163-Aged,
pubmed-meshheading:10509163-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:10509163-Colorectal Neoplasms,
pubmed-meshheading:10509163-Disease-Free Survival,
pubmed-meshheading:10509163-Female,
pubmed-meshheading:10509163-Fluorouracil,
pubmed-meshheading:10509163-Humans,
pubmed-meshheading:10509163-Leucovorin,
pubmed-meshheading:10509163-Lymphatic Metastasis,
pubmed-meshheading:10509163-Male,
pubmed-meshheading:10509163-Methotrexate,
pubmed-meshheading:10509163-Middle Aged,
pubmed-meshheading:10509163-Prognosis,
pubmed-meshheading:10509163-Quinazolines,
pubmed-meshheading:10509163-Survival Rate,
pubmed-meshheading:10509163-Thiophenes,
pubmed-meshheading:10509163-Treatment Outcome
|
|
pubmed:year |
1999
|
|
pubmed:articleTitle |
A phase II study of Tomudex alternated with methotrexate, 5-fluorouracil, leucovorin in first-line chemotherapy of metastatic colorectal cancer.
|
|
pubmed:affiliation |
Unità Operativa di Oncologia Medica, Azienda Ospedaliera Ospedale S. Salvatore, Pesaro, Italy.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Multicenter Study,
Clinical Trial, Phase II
|
